The following discussion and analysis of our results of operations and financial
condition should be read in conjunction with our consolidated financial
statements and related notes appearing elsewhere in this Quarterly Report on
Form 10-Q. This section includes a number of forward-looking statements, within
the meaning of the Private Securities Litigation Reform Act of 1995, that
reflect our current views with respect to future events and financial
performance. All statements that address expectations or projections about the
future, including, but not limited to, statements about our plans, strategies,
adequacy of resources and future financial results (such as revenue, gross
profit, operating profit, cash flow), are forward-looking statements. Some of
the forward-looking statements can be identified by words like "anticipates,"
"believes," "expects," "may," "will," "can," "could," "should," "intends,"
"project," "predict," "plans," "estimates," "goal," "target," "possible,"
"potential," "would," "seek," and similar references to future periods. These
statements are not guarantees of future performance and involve a number of
risks, uncertainties and assumptions that are difficult to predict. Because
these forward-looking statements are based on estimates and assumptions that are
subject to significant business, economic and competitive uncertainties, many of
which are beyond our control or are subject to change, actual outcomes and
results may differ materially from what is expressed or forecasted in these
forward-looking statements. Important factors that could cause actual results to
differ materially from these forward-looking statements include, but are not
limited to: negative outcome of pending and future claims and litigation; our
ability to access the capital markets by pursuing additional debt and equity
financing to fund our business plan and expenses on terms acceptable to us or at
all; and our ability to comply with our contractual covenants, including in
respect of our debt; potential cost overruns and possible rejection of our
business model and/or sales methods; weakness in general economic conditions and
levels of capital spending by customers in the industries we serve; weakness or
volatility in the financial and capital markets, which may result in the
postponement or cancellation of our customers' capital projects or the inability
of our customers to pay our fees; delays or reductions in U.S. government
spending; credit risks associated with our customers; competitive market
pressures; the availability and cost of qualified labor; our level of success in
attracting, training and retaining qualified management personnel and other
staff employees; changes in tax laws and other government regulations, including
the impact of health care reform laws and regulations; the possibility of
incurring liability for our business activities, including, but not limited to,
the activities of our temporary employees; our performance on customer
contracts; and government policies, legislation or judicial decisions adverse to
our businesses. Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof. We assume no
obligation to update such statements, whether as a result of new information,
future events or otherwise, except as required by law. We recommend readers to
carefully review the entirety of this Quarterly Report, including the "Risk
Factors" in Item 1A of this Quarterly Report and the other reports and documents
we file from time to time with the Securities and Exchange Commission ("SEC"),
particularly our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q
and our Current Reports on Form 8-K.



28






Overview



We are incorporated in the state of Delaware. As a rapidly growing public
company in the international staffing sector, our high-growth business model is
based on finding and acquiring suitable, mature, profitable, operating, U.S. and
U.K. based staffing companies. Our targeted consolidation model is focused
specifically on the Professional Business Stream and Commercial Business Stream
disciplines.



We effected a one-for-ten reverse stock split on June 24, 2022 (the "Reverse
Stock Split"). All share and per share information in the consolidated financial
statements has been retroactively adjusted to reflect the Reverse Stock Split.



Recent Developments



COVID-19



In December 2019, a strain of coronavirus ("COVID-19") was reported to have
surfaced in Wuhan, China, and has spread globally, resulting in
government-imposed quarantines, travel restrictions and other public health
safety measures in affected countries. The COVID-19 pandemic and its ongoing
effects are continuing to impact worldwide economic activity, and activity in
the United States and the United Kingdom where our operations are based. Much of
the independent contractor work we provide to our clients is performed at the
site of our clients. Given that the magnitude and duration of COVID-19's impact
on our business and operations remain uncertain, the continued spread of
COVID-19 (including the emergence and persistence of variants relating thereto)
and the imposition of related public health containment measures and travel and
business restrictions could have a material adverse impact on our business,
financial condition, operating results, and cash flows. While expected to be
temporary, prolonged workforce disruptions can negatively impact revenue in
fiscal year 2022 and the Company's overall liquidity.



While the ultimate economic impact brought by, and the duration of, the COVID-19
pandemic and its ongoing effects may be difficult to assess or predict, the
pandemic has resulted in significant disruptions in general commercial activity
and the global economy and caused financial market volatility and uncertainty in
significant and unforeseen ways in the recent years. A continuation or worsening
of the levels of market disruption and volatility seen in the recent past could
have an adverse effect on our ability to access capital and on the market price
of our common stock, and we may not be able to successfully raise needed
capital. If we are unsuccessful in raising capital in the future, we may need to
reduce activities, curtail, or cease operations.



In addition, the continuation or worsening of the COVID-19 pandemic, its ongoing
effects or an outbreak of other infectious diseases could result in a widespread
health crisis that could adversely affect the economies and financial markets
worldwide, resulting in an economic downturn that could impact our business,
financial condition, and results of operations.



29





Nasdaq Bid Price Requirement





On June 3, 2020, we received a letter from the Staff (the "Staff") of the Nasdaq
Stock Market ("Nasdaq") notifying us that we were no longer in compliance with
the minimum stockholders' equity requirement for continued listing on Nasdaq
under Nasdaq Listing Rule 5550(b)(1), which requires listed companies to
maintain stockholders' equity of at least $2,500 (the "Stockholders' Equity
Requirement"). A hearing before the Nasdaq Hearings Panel (the "Panel") was held
on January 21, 2021, and we were granted an extension to regain compliance until
February 28, 2021, which was subsequently further extended to May 31, 2021. On
June 28, 2021, we received a letter from the Staff notifying us that the Panel
determined that we had regained compliance with the Stockholders' Equity
Requirement. The Panel also imposed a panel monitor (the "Panel Monitor") under
Nasdaq Listing Rule 5815(d)(4)(A) for a period of one year from the date of the
June 28, 2021 letter, during which period we were expected to remain in
compliance with all of Nasdaq's continued listing requirements.



On February 23, 2022, we received a letter from the Listing Qualifications of
Nasdaq notifying us that we were no longer in compliance with Nasdaq Listing
Rule 5550(a)(2) (the "Bid Price Requirement"), for continued listing on Nasdaq.
Pursuant to the Panel Decision, we were not eligible for the 180-day bid price
compliance period set forth in the Listing Rules. On March 2, 2022, we timely
requested a hearing before the Panel, which was held on March 31, 2022. On April
12, 2022, we received a letter from Nasdaq notifying us that the Panel
determined to grant our request for continued listing on Nasdaq, subject to the
following: (i) on or about May 2, 2022, we would advise the Panel of the status
of the proxy statement it plans to file to obtain shareholder approval for a
reverse stock split, (ii) on or about May 23, 2022, we would advise the Panel on
the status of the shareholder meeting we plan to hold to obtain approval of the
reverse stock split, (iii) on or about May 26, 2022, we would affect a reverse
stock split and (iv) on or before about June 22, 2022, we would demonstrate
compliance with the Bid Price Requirement by evidencing a closing bid price
above $1.00 per share for the previous ten consecutive trading sessions. On each
of April 19, 2022 and May 20, 2022, we received letters from the Staff notifying
us that as we had not yet filed our Form 10-K for the period ended January 1,
2022 and our Form 10-Q for the period ended April 2, 2022, each such matter
serving as an additional basis for delisting our securities from Nasdaq under
Nasdaq Listing Rule 5810(c)(2)(A). On May 4, 2022 the Panel granted us an
extension request until July 11, 2022 to demonstrate compliance with the Bid
Price Requirement.



On June 23, 2022, we effected the Reverse Stock Split, on June 24, 2022, we
filed our Annual Report on Form 10-K for the year ended January 1, 2022, and on
July 14, 2022, we filed our Quarterly Report on Form 10-Q for the period ended
April 2, 2022. On July 15, 2022, we received a letter from the Staff informing
the Company that it had regained compliance with the Rule and the subsequent
delinquency concerns as described above. The letter additionally informed us
that we are in compliance with the terms of the Panel Monitor. We are now in
compliance with the listing requirements required for continued listing on
Nasdaq. Accordingly, the Panel determined to continue the listing of our
securities on Nasdaq and the matter is now closed.



30






July 2022 Private Placement



On July 1, 2022, we entered into a securities purchase agreement with certain
institutional and accredited investors for the issuance and sale of a private
placement of 657,858 shares of common stock or pre-funded warrants to purchase
shares of common stock, and warrants (the "July 2022 Warrants") to purchase up
to 657,858 shares of common stock, with an exercise price of $5.85 per share.
The July 2022 Warrants are exercisable immediately upon issuance and have a term
of exercise equal to five and one-half years from the date of issuance. The
combined purchase price for one share of common stock (or pre-funded warrant)
and one associated warrant to purchase one share of common stock was $6.10.



In connection with the private placement, each investor entered into Warrant
Amendment Agreements to amend the exercise prices of certain existing warrants
to purchase up to an aggregate of 657,858 shares of our common stock that were
previously issued to the investors, with exercise prices ranging from $18.50 to
$38.00 per share and expiration dates ranging from July 22, 2026 to November 1,
2026. The Warrant Amendment Agreements became effective upon the closing of the
July 2022 Private Placement and pursuant to the Warrant Amendment Agreements,
the amended warrants have a reduced exercise price of $5.85 per share and expire
five and one-half years following the closing of the July 2022 Private
Placement.



We intend to use the net proceeds received from the private placement for general working capital purposes.

Business Model, Operating History and Acquisitions





We are a high-growth international staffing company engaged in the acquisition
of U.S. and U.K. based staffing companies. As part of our consolidation model,
we pursue a broad spectrum of staffing companies supporting primarily the
Professional and Commercial Business Streams. Our typical acquisition model is
based on paying consideration in the form of cash, stock, earn-outs and/or
promissory notes. In furthering our business model, we are regularly in
discussions and negotiations with various suitable, mature acquisition targets.
Since November 2013, we have completed eleven acquisitions.



31





For the Nine Months Ended October 1, 2022 and October 2, 2021





                               Nine Months                        Nine Months
                                  Ended                              Ended
                               October 1,                         October 2,
                                  2022          % of Revenue         2021         % of Revenue       Growth
Revenue                        $   175,066              100.0 %   $   146,982             100.0 %        19.1 %
Cost of revenue                    143,709               82.1 %       120,324              81.9 %        19.4 %
Gross profit                        31,357               17.9 %        26,658              18.1 %        17.6 %
Operating expenses                  32,556               18.6 %        27,933              19.0 %        16.6 %
Loss from operations                (1,199 )             -0.7 %        (1,275 )            -0.9 %        -6.0 %
Other (expenses) income             (2,292 )             -1.3 %        16,250              11.1 %      -114.1 %
Benefit (Provision) for                    )                                                                  %
income taxes                           (65                0.0 %          (102 )            -0.1 %       -36.3
Net (loss) income              $    (3,556 )             -2.0 %   $    14,873              10.1 %      -123.9 %




Revenue


For the nine months ended October 1, 2022, revenue increased by 19.1% to $175,066 as compared with $146,982 for the nine months ended October 2, 2021. Of that $28,084 increase, $33,074 was attributable to the Headway acquisition, partially offset by $311 organic revenue decline and $4,679 of unfavorable foreign currency translation.


Revenue for the nine months ended October 1, 2022 was comprised of $170,699 of
temporary contractor revenue and $4,367 of permanent placement revenue, compared
with $143,274 of temporary contractor revenue and $3,708 of permanent placement
revenue for the nine months ended October 2, 2021, respectively.



Cost of revenue, Gross profit and Gross margin





Cost of revenue, excluding depreciation and amortization, includes the variable
cost of labor and various non-variable costs (e.g., workers' compensation
insurance) relating to employees (temporary and permanent) as well as
sub-contractors and consultants. For the nine months ended October 1, 2022, cost
of revenue was $143,709, an increase of 19.4% from $120,324 for the nine months
ended October 2, 2021, compared with revenue growth of 19.1%. Of that $23,385
increase, $28,049 was attributable to the Headway acquisition offset by a $778
decline in associated costs of our operations and $3,886 of favorable foreign
currency translation.



Gross profit for the nine months ended October 1, 2022 was $31,357, an increase
of 17.9% from $26,658 for the nine months ended October 2, 2021, representing
gross margin of 17.9% and 18.1% for each period, respectively. The $4,699
increase was driven by $5,025 from the Headway acquisition and $468 of organic
growth and partially offset by $794 of unfavorable foreign currency translation.



32






Operating expenses



Total operating expenses for the nine months ended October 1, 2022 were $32,556,
an increase of 16.6% from $27,933 for the nine months ended October 2, 2021. The
increase of $4,623 was driven primarily by Headway operating expenses of $4,450
as well as higher non-recurring costs, legal costs, and other costs associated
with acquisitions efforts.



Other expenses



Total other (expenses) income for the nine months ended October 1, 2022 were
$(2,292), a decrease of 114.1% from $16,250 in the nine months ended October 2,
2021. The decrease was driven by the following: PPP forgiveness gain of $19,395
for the nine months ended October 2, 2021 compared to $0 for the nine months
ended October 1, 2022, $3,030 interest expense and amortization of debt discount
and deferred financing costs in the nine months ended October 1, 2022, which
includes interest expense and amortization of $299 from the Headway acquisition,
compared with the nine months ended October 2, 2021 of $(3,432), remeasuring our
intercompany note for the nine months ended October 1, 2022 of $0 compared with
losses from remeasuring our intercompany note in the nine months ended October
2, 2021 of $219. In addition, for the nine months ended October 1, 2022, we had
other income of $738 compared to other income of $292 for the nine months ended
October 2, 2021.


For the Three Months Ended October 1, 2022 and October 2, 2021





                                  Three                              Three
                                 Months                             Months
                                  Ended                              Ended
                               October 1,                         October 2,
                                  2022          % of Revenue         2021         % of Revenue       Growth
Revenue                        $    66,120              100.0 %   $    47,501             100.0 %        39.2 %
Cost of revenue                     53,795               81.4 %        37,877              79.7 %        42.0 %
Gross profit                        12,325               18.6 %         9,624              20.3 %        28.1 %
Operating expenses                  11,830               17.9 %         9,151              19.3 %        29.3 %
Loss from operations                   495                0.7 %           473               1.0 %         4.7 %
Other (expenses) income                599                0.9 %         8,371              17.6 %       -92.8 %
Benefit (expense) from
income taxes                           (62 )             -0.1 %          (131 )            -0.3 %       -52.7 %
Net (loss) income              $     1,032                1.6 %   $     8,713              18.3 %       -88.2 %




Revenue



For the three months ended October 1, 2022, revenue increased by 39.2% to
$66,120 as compared with $47,501 for the three months ended October 2, 2021. Of
that $18,619 increase, $21,822 was attributable to the Headway acquisition which
was partially offset by a $770 decrease in the Company's other operations and
$2,433 of unfavorable foreign currency translation.



Revenue for the three months ended October 1, 2022 was comprised of $64,733 of
temporary contractor revenue and $1,387 of permanent placement revenue, compared
with $46,168 and $1,333 for the three months ended October 2, 2021,
respectively.



Cost of revenue, Gross profit and Gross margin





Cost of revenue, excluding depreciation and amortization, includes the variable
cost of labor and various non-variable costs (e.g., workers' compensation
insurance) relating to employees (temporary and permanent) as well as
sub-contractors and consultants. For the three months ended October 1, 2022,
cost of revenue was $53,795, an increase of 42.0% from $37,877 in the three
months ended October 2, 2021, compared with revenue growth of 39.2%. Of that
$15,918 increase, $18,129 was attributable to the Headway acquisition which was
partially offset by a $209 decline in associated costs of the Company's other
operations and $2,002 of favorable foreign currency translation.



Gross profit for the three months ended October 1, 2022 was $12,325, an increase
of 28.1% from $9,624 for the three months ended October 2, 2021, representing
gross margin of 18.6% and 20.3% for each period, respectively. The increase of
$2,701 was driven by $3,693 from the Headway acquisition and partially offset by
$564 of loss from our other operations and $428 of unfavorable foreign currency
translation.



33






Operating expenses



Total operating expenses for the three months ended October 1, 2022 were
$11,830, an increase of 29.3% from $9,151 for the three months ended October 2,
2021. The increase of $2,679 was driven primarily by Headway operating expenses
of $2,856 which was offset by a reduction in non-recurring costs, legal, and
other costs associated with acquisitions efforts.



Other expenses



Total other expenses for the three months ended October 1, 2022 was $410, a
decrease of 92.8% from other income of $8,371 in the three months ended October
2, 2021. The decrease was driven by the following: PPP forgiveness gain of
$9,504 for the three months ended October 2, 2021 compared to $0 for the three
months ended October 1, 2022, $1,127 interest expense and amortization of debt
discount and deferred financing costs in the three months ended October 1, 2022,
which includes interest expense and amortization of $187 from the Headway
acquisition, compared with the three months ended October 2, 2021 of $1,006,
gain from remeasuring our intercompany note in the three months ended October 1,
2022 of $1,009 compared with loss from remeasuring our intercompany note in the
three months ended October 2, 2021 of $315. In addition, in the three months
ended October 1, 2022, we had other income of $717 compared with other loss of
$188 for the three months ended October 2, 2021.



Non-GAAP Measures



To supplement our consolidated financial statements presented in accordance with
GAAP, we also use non-GAAP financial measures and Key Performance Indicators
("KPIs") in addition to our GAAP results. We believe non-GAAP financial measures
and KPIs may provide useful information for evaluating our cash operating
performance, ability to service debt, compliance with debt covenants and
measurement against competitors. This information should be considered as
supplemental in nature and should not be considered in isolation or as a
substitute for the related financial information prepared in accordance with
GAAP. In addition, these non-GAAP financial measures may not be comparable to
similarly entitled measures reported by other companies.



We present the following non-GAAP financial measure and KPIs in this report:


Revenue and Gross Profit by Business Streams We use this KPI to measure our mix
of Revenue and respective Gross Profit between its two main lines of business
due to their differing margins. For clarity, these lines of business are not our
operating segments, as this information is not currently regularly reviewed by
the chief operating decision maker to allocate capital and resources. Rather, we
use this KPI to benchmark us against the industry.



The following table details Revenue and Gross Profit by sector:





                                           Three Months Ended                                   Nine Months Ended
                             October 1,                October 2,                October 1,                October 2,
                                2022         Mix          2021         Mix          2022         Mix          2021         Mix

Revenue

Commercial Staffing - US $ 25,940 39 % $ 29,601 62 % $ 83,350 48 % $ 88,240 60 % Professional Staffing - US 25,756 39 % 4,536 10 % 45,292 26 % 12,215 8 % Professional Staffing - UK 14,424 22 % 13,364 28 % 46,424 27 % 46,527 32 % Total Service Revenue $ 66,120

$   47,501                $  175,066                $  146,982

Gross Profit
Commercial Staffing - US     $    5,034         41 %   $    5,195         54 %   $   15,197         48 %   $   15,422         58 %
Professional Staffing - US        4,715         38 %        1,200         12 %        8,286         26 %        3,146         12 %
Professional Staffing - UK        2,576         21 %        3,229         34 %        7,874         25 %        8,090         30 %
Total Gross Profit           $   12,325                $    9,624                $   31,357                $   26,658

Gross Margin
Commercial Staffing - US           19.4 %                    17.6 %                    18.2 %                    17.5 %
Professional Staffing - US         18.3 %                    26.5 %                    18.3 %                    25.8 %
Professional Staffing - UK         17.9 %                    24.2 %                    17.0 %                    17.4 %
Total Gross Margin                 18.6 %                    20.3 %                    17.9 %                    18.1 %




Adjusted EBITDA This measure is defined as net income (loss) attributable to
common stock before: interest expense, benefit from income taxes; depreciation
and amortization; acquisition, capital raising and other non-recurring expenses;
other non-cash charges; impairment of goodwill; re-measurement gain on
intercompany note; restructuring charges; gain from sale of business; PPP
Forgiveness Gain; other income; and charges we consider to be non-recurring in
nature such as legal expenses associated with litigation, professional fees
associated potential and completed acquisitions. We use this measure because we
believe it provides a more meaningful understanding of our profit and cash

flow
generation.



34






                                       Three Months Ended             Nine Months Ended           Trailing Twelve Months
                                   October 1,      October 2,     October 1,     October 2,     October 1,       October 2,
                                      2022            2021           2022           2021           2022             2021
Net loss                           $     1,032     $    8,713     $   (3,556 )   $   14,873     $   (10,200 )    $   12,632

Interest expense                           891            814          2,512          3,068           3,301           4,506
(Benefit) expense from income
taxes                                       62            131             65            102            (392 )           247
Depreciation and amortization            1,023            880          2,658          2,486           3,289           3,330
EBITDA                             $     3,008     $   10,538     $    

1,679 $ 20,529 $ (4,073 ) $ 20,715



Acquisition, capital raising and
other non-recurring expenses (1)         1,788            321          4,375          2,802           4,847           5,024
Other non-cash charges (2)                   7              8             32            344             253             450
Impairment of Goodwill                       -              -              -              -           3,104               -
Re-measurement gain on
intercompany note                       (1,009 )          315              -            219               -            (712 )
Deferred consideration
settlement                                   -              -              -              -               -              41
PPP Forgiveness Gain                         -         (9,504 )            -        (19,609 )             -         (19,609 )
Gain on sale of business                     -              -              -              -               -              95
Other (income) loss                       (717 )         (188 )         (738 )         (292 )          (412 )          (296 )
Adjusted EBITDA                    $     3,077     $    1,490     $    5,348     $    3,993     $     3,719      $    5,708

Adjusted EBITDA of Divested
Business (3)                                                                                    $         -      $      101
Pro Forma Adjusted EBITDA (4)                                                                   $     3,719      $    5,809

Adjusted Gross Profit (5)                                                                       $    35,866      $   34,945

Adjusted EBITDA as percentage of
Adjusted Gross Profit                                                                                  10.4 %          16.6 %



(1) Acquisition, capital raising, and other non-recurring expenses primarily

relate to capital raising expenses, acquisition and integration expenses,

and legal expenses incurred in relation to matters outside the ordinary

course of business. Due to government mandated restrictions, the Company had

to temporarily close some of its offices and, due to social distancing

restrictions, could not make full use of these facilities for significant

periods of time during 2021.

(2) Other non-cash charges primarily relate to staff option and share

compensation expense, expense for shares issued to directors for board

services, and consideration paid for consulting services.

(3) Adjusted EBITDA of Divested Business for the period prior to the divestment

date.

(4) Pro Forma Adjusted EBITDA excludes the Adjusted EBITDA of Divested Business


      for the period prior to the divestment date.

  (5) Adjusted Gross Profit excludes gross profit of business divested in
      September 2020, for the period prior to divestment date.




Operating Leverage This measure is calculated by dividing the growth in Adjusted
EBITDA by the growth in Adjusted Gross Profit, on a trailing 12-month basis. We
use this KPI because we believe it provides a measure of our efficiency for
converting incremental gross profit into Adjusted EBITDA.



35






                                          October 1, 2022       October 2, 2021

Gross Profit - TTM (Current Period) $ 35,866 $ 34,945 Gross Profit - TTM (Prior Period)

                   34,945                

32,479


Gross Profit - Growth (Decline)          $             921     $          

2,466


Adjusted EBITDA - TTM (Current Period)   $           3,719     $          

5,708


Adjusted EBITDA - TTM (Prior Period)                 5,708                

5,442


Adjusted EBITDA - Growth (Decline)       $          (1,989 )   $           

 266

Operating Leverage                                  -216.0 %                10.8 %




Leverage Ratio Calculated as Total Debt, Net, gross of any Original Issue
Discount (includes Redeemable Series H Preferred Stock), divided by Pro Forma
Adjusted EBITDA for the trailing 12-months. We use this KPI as an indicator of
our ability to service debt prospectively.



                                                             October 1, 2022       October 2, 2021

Total Term Debt, Net                                        $          17,701     $          14,357
Addback: Total Debt Discount and Deferred Financing Costs                 660                   235
Total Debt                                                  $          18,361     $          14,592

TTM Adjusted EBITDA                                         $           3,759     $           5,708

Pro Forma TTM Adjusted EBITDA                               $           3,759     $           5,809

Pro Forma Leverage Ratio                                                 4.88 x                 2.5 x




Operating Cash Flow Including Proceeds from Accounts Receivable Financing
calculated as net cash (used in) provided by operating activities plus net
proceeds from accounts receivable financing. Because much of our temporary
payroll expense is paid weekly and in advance of clients remitting payment for
invoices, operating cash flow is often weaker in staffing companies where
revenue and accounts receivable are growing. Accounts receivable financing is
essentially an advance on client remittances and is primarily used to fund
temporary payroll. As such, we believe this measure is helpful to investors as
an indicator of our underlying operating cash flow.



On February 8, 2018, CBS Butler Holdings Limited ("CBS Butler"), Staffing 360
Solutions Limited and The JM Group, entered into a new arrangement with HSBC
Invoice Finance (UK) Ltd ("HSBC") which provides for HSBC to purchase the
subsidiaries' accounts receivable up to an aggregate amount of £11,500 across
all three subsidiaries. The terms of the arrangement provide for HSBC to fund
90% of the purchased accounts receivable upfront and a secured borrowing line of
70% of unbilled receivables capped at £1,000 (within the overall aggregate total
facility of £11,500). The arrangement has an initial term of 12 months, with an
automatic rolling three-month extension and carries a service charge of 1.80%.
Under ASU 2016-16, "Statement of Cash Flows (Topic 230, Classification of
Certain Cash Receipts and Cash Payments, a consensus of the FASB Emerging Issues
Task Force), the upfront portion of the sale of accounts receivable is
classified within operating activities, while the deferred purchase price
portion (or beneficial interest), once collected, is classified within investing
activities. On April 20, 2020, the terms of the loan with HSBC were amended
whereby no capital repayments will be made between April 2020 to September 2020,
and only interest payments will be made during this time. On May 15, 2020, we
entered into a three-year term loan with HSBC in the UK for £1,000.

© Edgar Online, source Glimpses